ReviewThe oncologist2018

Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations.

Kathleen N Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.